"We are going to have lung cancer patients living longer and better:" A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)

Wikimedia Commons New cancer treatments that harness the body's immune system are ready to go mainstream.  In data presente.....»»

Category: topSource: businessinsiderApr 16th, 2018

Cellectar stock surges 15% premarket after FDA fast tracks treatment for rare childhood cancer

Cellectar Biosciences Inc. said Monday it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for a treatment for a rare kind of cancer in children cal.....»»

Category: topSource: marketwatchSep 17th, 2018

AstraZeneca"s Tagrisso Wins EU Nod for First-Line Lung Cancer

AstraZeneca's (AZN) Tagrisso gets an EU nod for first-line treatment of advanced or metastatic non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) m.....»»

Category: personnelSource: nytJun 11th, 2018

Study finds rare gain for tough-to-treat pancreatic cancer

Patients with pancreatic cancer that hadn't spread lived substantially longer on .....»»

Category: topSource: foxnewsJun 4th, 2018

A cancer treatment that one expert called the "most exciting thing I"ve seen in my lifetime" just got approved to treat more patients (NVS, GILD)

Reuters The FDA just approved a cutting-edge .....»»

Category: topSource: businessinsiderMay 2nd, 2018

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

A combination of Merck's Keytruda and chemotherapy cut lung cancer death rates in half. New study results released Monday continue to cemen.....»»

Category: europeSource: fortuneApr 16th, 2018

Merck"s Keytruda helps lung cancer patients live longer in trial

(Reuters) - Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in the lucrative lung cancer market......»»

Category: topSource: reutersApr 9th, 2018

Merck"s Keytruda meets main goal in pivotal lung cancer trial

(Reuters) - Merck & Co said on Monday a late-stage trial of its blockbuster cancer drug Keytruda met the main goal in helping previously untreated lung cancer patients live longer, sending its shares up 2.6 percent in premarket trade......»»

Category: topSource: reutersApr 9th, 2018

Bristol-Myers says trial of small cell lung cancer treatment failed to meet main goal

Bristol-Myers Squibb Co. said Friday a late-stage trial of a treatment for small cell lung cancer failed to meet its main .....»»

Category: topSource: marketwatchOct 12th, 2018

The FDA just approved the second of a new kind of medication that could change the way we treat a condition that affects 39 million Americans (TEVA)

Johan Swanepoel/Shutterstock The FDA on Friday approved a new preventative migraine treatment made by Israeli drugmaker Teva.....»»

Category: topSource: businessinsiderSep 17th, 2018

Cytori treatment of small cell lung cancer granted orphan designation

See the rest of the story here. provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Sen. John McCain to stop medical treatment, family says

The family of Sen. John McCain said Friday that the Arizona Republican will no longer be treated for the brain cancer he has been battling. "With his usual strength of will, he has now chosen to discontinu.....»»

Category: topSource: marketwatchAug 24th, 2018

Roche"s Lung Cancer Drug Alecensa Gets Approval in China

The China National Drug Administration approves Roche's (RHHBY) cancer drug Alecensa as a monotherapy for first-line treatment of advanced non-small ce.....»»

Category: smallbizSource: nytAug 20th, 2018

Bristol-Myers wins FDA approval for Opdivo as treatment for small cell lung cancer

Bristol-Myers Squibb Co. said Friday the U.S. Food and Drug Admi.....»»

Category: topSource: marketwatchAug 17th, 2018

Bristol-Myers says FDA has approved opdivo as treatment for small cell lung cancer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 17th, 2018

BMO, Oppenheimer Out Bullish On Constellation Pharma"s Cancer Treatment Opportunity

The development-stage biotechnology company Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) uses protein interaction to treat myelofibrosis, in addition to addressing prostate cancer and other tumors. Latest Ratings for CNST DateF.....»»

Category: blogSource: benzingaAug 13th, 2018

Merck"s Keytruda Gets Priority Review in Difficult Lung Cancer

Merck's (MRK) sBLA looking to expand the label of Keytruda for first-line treatment of metastatic squamous NSCLC gets FDA's priority review. The decisio.....»»

Category: worldSource: nytJul 3rd, 2018

Merck"s (MRK) Keytruda Gets FDA Approval for Cervical Cancer

Merck's (MRK) Keytruda receives accelerated approval for the treatment of patients with advanced cervical cancer. Merck MRK has received FDA’s accelerated approval for label.....»»

Category: smallbizSource: nytJun 13th, 2018

A study of more than 10,000 breast cancer patients found that some can skip chemotherapy without hurting their chances of beating the disease

Thomson Reuters A study found that around 70,000 early-stage breast cancer patients a year could safely skip chemotherapy without hurting their chances of beating the disease. The study used a genetic te.....»»

Category: topSource: businessinsiderJun 4th, 2018

The Wall Street Journal: Cancer researchers suggest ‘less is more’ approach to treatment

Cancer researchers are increasingly exploring whether they can eliminate or scale back treatments to spare patients from tough side effects — and costs — without jeopardizing survival......»»

Category: topSource: marketwatchJun 3rd, 2018

Many breast cancer patients can skip chemo, big study finds

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk......»»

Category: topSource: foxnewsJun 3rd, 2018